PubMed (cited) for id: 602643

Year	Number of Results
1979	1
1997	3
1998	4
1999	1
2001	1
2002	6
2003	3
2004	2
2005	1
2008	1
2012	1
2014	1
2024	0

1

Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease.

Naot D, Choi A, Musson DS, Simsek Kiper PÖ, Utine GE, Boduroglu K, Peacock M, DiMeglio LA, Cundy T. Naot D, et al. Bone. 2014 Nov;68:6-10. doi: 10.1016/j.bone.2014.07.034. Epub 2014 Aug 6. Bone. 2014. PMID: 25108083

2

Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin.

Luan X, Lu Q, Jiang Y, Zhang S, Wang Q, Yuan H, Zhao W, Wang J, Wang X. Luan X, et al. J Immunol. 2012 Jul 1;189(1):245-52. doi: 10.4049/jimmunol.1103387. Epub 2012 Jun 4. J Immunol. 2012. PMID: 22664871

3

Multiple genetic loci for bone mineral density and fractures.

Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K. Styrkarsdottir U, et al. N Engl J Med. 2008 May 29;358(22):2355-65. doi: 10.1056/NEJMoa0801197. Epub 2008 Apr 29. N Engl J Med. 2008. PMID: 18445777 Free article.

4

Recombinant osteoprotegerin for juvenile Paget's disease.

Cundy T, Davidson J, Rutland MD, Stewart C, DePaoli AM. Cundy T, et al. N Engl J Med. 2005 Sep 1;353(9):918-23. doi: 10.1056/NEJMoa050893. N Engl J Med. 2005. PMID: 16135836 Free article.

5

Osteoprotegerin gene polymorphisms in men with coronary artery disease.

Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR. Soufi M, et al. J Clin Endocrinol Metab. 2004 Aug;89(8):3764-8. doi: 10.1210/jc.2003-032054. J Clin Endocrinol Metab. 2004. PMID: 15292302

6

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.

Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J. Kiechl S, et al. Circulation. 2004 May 11;109(18):2175-80. doi: 10.1161/01.CIR.0000127957.43874.BB. Epub 2004 Apr 26. Circulation. 2004. PMID: 15117849

7

Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.

Chong B, Hegde M, Fawkner M, Simonet S, Cassinelli H, Coker M, Kanis J, Seidel J, Tau C, Tüysüz B, Yüksel B, Love D; International Hyperphosphatasia Collaborative Group. Chong B, et al. J Bone Miner Res. 2003 Dec;18(12):2095-104. doi: 10.1359/jbmr.2003.18.12.2095. J Bone Miner Res. 2003. PMID: 14672344 Free article.

8

Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.

Viereck V, Gründker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch KH, Raddatz D, Emons G, Hofbauer LC. Viereck V, et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4206-13. doi: 10.1210/jc.2002-021877. J Clin Endocrinol Metab. 2003. PMID: 12970288

9

Serum osteoprotegerin in adolescent girls with anorexia nervosa.

Misra M, Soyka LA, Miller KK, Herzog DB, Grinspoon S, De Chen D, Neubauer G, Klibanski A. Misra M, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3816-22. doi: 10.1210/jc.2003-030088. J Clin Endocrinol Metab. 2003. PMID: 12915674 Clinical Trial.

10

Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.

Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J. Arko B, et al. J Clin Endocrinol Metab. 2002 Sep;87(9):4080-4. doi: 10.1210/jc.2002-020124. J Clin Endocrinol Metab. 2002. PMID: 12213850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year